Plasma-derived medicinal products are gaining recognition as critical medicines. Most recently, Germany followed the United Kingdom in exempting PDMPs from an additional mandatory rebate. https://lnkd.in/g9hK2f7G #raredisease #plasma #patientaccess #CSL
Plasma's Life-Saving Journey Video Series
We explain how donated plasma becomes medicine for those
with rare, life-threatening conditions
Like to learn more about Our Impact? Click here to view or download the 2025 Impact Report → | Would you like to read our 2025 Annual Report? Click here to view or download the Annual Report → | CSL's 2025 Full Year Financial Results Click here for Full Information including Webcast Recording →
CSL. Always Evolving for a Better World.
CSL has delivered biotechnology excellence for over a century. Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need. We’re always improving so life can, too.
Our Businesses and Products
CSL. Always Evolving for a Better World.
CSL has delivered biotechnology excellence for over a century. Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need. We’re always improving so life can, too.
Our Businesses and Products
CSL Behring. Leading the Way in Treating Rare and Serious Diseases.
CSL Behring is a global biotech leader with a broad range of biotherapies for rare and serious diseases including bleeding disorders, immunodeficiencies, hereditary angioedema, neurological disorders and Alpha 1 Antitrypsin Deficiency.
More About CSL Behring
CSL Seqirus. Global Vaccine Leader.
Through the power of innovation, our vision is to advance science to enhance public health worldwide. We stand on the front line with partners in public health discovering, developing, and delivering pioneering vaccine solutions to safeguard people and communities across the world.
More About CSL Seqirus
CSL Vifor. Changing the Game in Iron Deficiency and Nephrology.
The newest member of the CSL family, CSL Vifor is a global leader in iron deficiency and nephrology and is committed to launching the next generation of therapies to truly address the full spectrum of kidney disease, with a focus on dialysis and rare disease.
More About CSL ViforVita: Original Stories
'Vita' means life. It's also where we share the stories of biotech's promise to patients and public health.
Careers at CSL
We are committed to helping employees fulfill their career aspirations while working in a values-based culture. Are you next?
Pictured: CSL employees in Melbourne, Australia
28 Jul
27 Jul
Encouraging news for the hereditary angioedema \(HAE\) community: CSL announced positive top-line Phase 3b study results in children aged 2–11 years. Learn more in our newsroom: https://newsroom.csl.com
27 Jul
What does it take to lead clinical trials that could change lives? For Jeremy, it starts with patients. Early in his career, he saw firsthand the trust patients place in research. Today, he leads global clinical operations for a Phase 3 trial focused on preventing heart attacks in patients with end-stage kidney disease. That responsibility, and possibility, is what drives him. Join CSL’s R&D team and help make a meaningful impact for patients worldwide: https://lnkd.in/dbhEc33c #ClinicalResearch #PeoplePoweringScience #CSL #CSLCareers
26 Jul
Ready for a change? At CSL, your work can help advance innovative therapies that improve and save lives around the world. Join a team where curiosity is encouraged, growth is supported, and your contributions can make a meaningful impact. Explore opportunities to build what’s next in your career: https://lnkd.in/gdJy4DQv #CSLCareers #Innovation #LifeSciences #CSL
24 Jul
At CSL, we believe people living with hemophilia B, their families, caregivers and healthcare teams deserve timely, transparent communication. Today, we shared a community update reaffirming our commitment to the hemophilia B community and keeping stakeholders informed as new information becomes available. We thank the patient organizations, healthcare professionals, treatment centers and community advocates whose ongoing partnership helps strengthen support for those affected by hemophilia B. Read the full community letter: https://bit.ly/3ThnYv0 #HemophiliaB #RareDisease #PatientCommunity #DrivenByOurPromise
22 Jul
“Research trials are challenging work. But it suits me because I'm very curious. I love the science. And I love being able to do difficult things and try to overcome those challenges." Jeremy is leading the clinical trials of the world’s first drug designed to prevent heart attacks in end stage kidney disease patients. Read Jeremy's story here: https://lnkd.in/et-3RGzZ #CSL #PeoplePoweringScience
15 Jul
"After years of research, bringing a project to life as a clinical trial is incredibly energizing. Each trial represents progress, and each milestone is one step closer to getting potential new medicines to patients." Mollie helps our research teams turn promising science into clinical trials, so we can get new, effective and safe medicines to patients as quickly as possible. Read Mollie's Story here: https://lnkd.in/et-3RGzZ #CSL #PeoplePoweringScience
14 Jul
Each drop of plasma carries incredible therapeutic potential, and the next step on its extraordinary journey is fractionation. The third video in our #PlasmaSeries continues with Markus Ries. As Value Stream Lead overseeing and leading all fractionation activities at our Marburg, Germany site, he explains the scientific precision and state-of-the-art techniques CSL uses across our global facilities to transform plasma into life-changing therapies. Discover the science of saving lives in the video below and learn more here: https://bit.ly/4x5wwol #CSL #PlasmaDonation #PlasmaDerivedTherapies
8 Jul
"When I was younger, I didn’t really understand the idea of purpose. Over time, that changed. I realised that even a small contribution can make someone’s life easier. There are many diseases that need treatment, and I hope that through innovation we can progress medicines that make life easier, if not cure diseases." Olga and her team work with health authorities to get new medicines to patients around the world. Read Olga's story here: https://lnkd.in/eXt5QmjQ #CSL #PeoplePoweringScience
13 Jul
What drives scientists to keep exploring the unknown? For Olga Neumueller, it starts with curiosity. At CSL, she works at the intersection of science, strategy and collaboration to help advance therapies that could make a meaningful difference for patients worldwide. Because discovery starts with asking the next question. Explore how you can make an impact at CSL: https://lnkd.in/dbhEc33c #PeoplePoweringScience #CSLCareers #Innovation #Research #CSLCareers #CSL